Skip to main content
Predictive Oncology Inc. logo

Predictive Oncology Inc. — Investor Relations & Filings

Ticker · POAI ISIN · US74039M3097 US Professional, scientific and technical activities
Open in API
Filings indexed 1,215 across all filing types
Latest filing 2025-12-10 Regulatory Filings
Country US United States of America
Listing US POAI

About Predictive Oncology Inc.

https://predictive-oncology.com/

Predictive Oncology is a science-driven company that applies artificial intelligence (AI) and machine learning to oncology drug discovery and development. The company's core platform integrates its predictive AI engine with a proprietary biobank containing over 150,000 human tumor samples. This enables high-confidence predictions of drug response, helping biopharmaceutical partners de-risk development and select promising drug-tumor combinations in the pre-clinical phase. The company also provides advanced 3D tumor models that mimic the human physiological environment for more clinically relevant testing. Additionally, its clinical laboratory offers tumor drug-response and genomic biomarker testing services to support the personalization of cancer therapies.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes a corporate name change, amendments to the certificate of incorporation and bylaws, and a change in ticker symbol. There are no financial statements or detailed financial data presented, nor is this an earnings release or annual/interim report. The document is not a proxy statement, voting results, or a remuneration report. It is a regulatory announcement of corporate governance changes and related filings. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2025-12-10 English
Director's Dealing 2025
Director's Dealing
2025-12-03 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content discusses a Nasdaq compliance matter regarding stockholders' equity and the closing of a previously disclosed listing issue. It also mentions a press release about regaining compliance. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is an announcement of a regulatory event related to listing compliance, not a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-02 English
Regulatory Filings 2025
Regulatory Filings
2025-11-26 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated November 25, 2025, for Predictive Oncology Inc. It includes detailed voting results from the company's 2025 annual meeting of stockholders, including election of directors, ratification of auditors, approval of equity plan amendments, and advisory votes on executive compensation. The content focuses on shareholder meeting outcomes and related corporate governance matters. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is over 5,000 characters and contains substantive voting data, not just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2025-11-25 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) related to the resale of shares of common stock by selling stockholders. It includes detailed information about the offering, risk factors, use of proceeds, description of capital stock, selling stockholders, dividend policy, plan of distribution, legal matters, and other related disclosures. The document is a registration statement prospectus, which is a type of capital raising document. It is not an annual report, earnings release, management discussion, or any other type of report. It is specifically related to securities offering and resale by selling stockholders, which fits the category of Capital/Financing Update (CAP).
2025-11-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.